Brian Mueller Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Brian Mueller.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Brian Mueller. Brian Mueller is VP, Corporate Controller in BIOMARIN PHARMACEUTICAL INC ($BMRN).
Latest Insider Trading Transactions of Brian Mueller
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 03 2014 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | M | 28.23 | 5,000 | 141,150 | 14,491 | |
Dec 03 2014 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | M | 21.51 | 6,429 | 138,288 | 0 | |
Dec 03 2014 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | M | 14.39 | 521 | 7,497 | 0 | |
Dec 03 2014 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Sell | S | 91.82 | 5,000 | 459,100 | 4,593 | 9.6 K to 4.6 K (-52.12 %) |
Dec 03 2014 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Buy | M | 28.23 | 5,000 | 141,150 | 9,593 | 4.6 K to 9.6 K (+108.86 %) |
Dec 03 2014 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Sell | S | 90.25 | 6,950 | 627,238 | 4,593 | 11.5 K to 4.6 K (-60.21 %) |
Dec 03 2014 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Buy | M | 21.51 | 6,429 | 138,288 | 11,543 | 5.1 K to 11.5 K (+125.71 %) |
Dec 03 2014 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Buy | M | 14.39 | 521 | 7,497 | 5,114 | 4.6 K to 5.1 K (+11.34 %) |
Dec 02 2014 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Sell | S | 88.97 | 3,400 | 302,508 | 4,593 | 8 K to 4.6 K (-42.54 %) |
Jun 03 2014 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Payment of Exercise | F | 57.96 | 297 | 17,214 | 7,993 | 8.3 K to 8 K (-3.58 %) |
May 16 2014 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Payment of Exercise | F | 57.44 | 207 | 11,890 | 8,290 | 8.5 K to 8.3 K (-2.44 %) |
May 14 2014 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Payment of Exercise | F | 59.30 | 282 | 16,723 | 8,497 | 8.8 K to 8.5 K (-3.21 %) |
May 12 2014 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Grant | A | 29.69 | 498 | 14,786 | 8,779 | 8.3 K to 8.8 K (+6.01 %) |
May 12 2014 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Payment of Exercise | F | 56.78 | 444 | 25,210 | 8,281 | 8.7 K to 8.3 K (-5.09 %) |
Jun 04 2013 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Payment of Exercise | F | 62.70 | 413 | 25,895 | 8,447 | 8.9 K to 8.4 K (-4.66 %) |
May 17 2013 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | A | 67.81 | 12,900 | 874,749 | 12,900 | |
May 17 2013 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Grant | A | 0.00 | 2,200 | 0 | 8,860 | 6.7 K to 8.9 K (+33.03 %) |
May 15 2013 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | M | 21.51 | 3,500 | 75,285 | 6,429 | |
May 15 2013 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Sell | S | 70.33 | 3,500 | 246,155 | 6,660 | 10.2 K to 6.7 K (-34.45 %) |
May 15 2013 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Buy | M | 21.51 | 3,500 | 75,285 | 10,160 | 6.7 K to 10.2 K (+52.55 %) |
May 15 2013 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Sell | S | 70.41 | 1,447 | 101,890 | 6,660 | 8.1 K to 6.7 K (-17.85 %) |
May 14 2013 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Payment of Exercise | F | 67.68 | 817 | 55,295 | 8,107 | 8.9 K to 8.1 K (-9.16 %) |
May 14 2013 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Payment of Exercise | F | 65.32 | 479 | 31,288 | 8,924 | 9.4 K to 8.9 K (-5.09 %) |
May 06 2013 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | M | 14.39 | 4,874 | 70,137 | 521 | |
May 06 2013 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | M | 21.51 | 7,500 | 161,325 | 15,200 | |
May 06 2013 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Sell | S | 67.11 | 7,500 | 503,295 | 9,403 | 16.9 K to 9.4 K (-44.37 %) |
May 06 2013 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Buy | M | 21.51 | 7,500 | 161,325 | 16,903 | 9.4 K to 16.9 K (+79.76 %) |
May 06 2013 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Sell | S | 65.48 | 4,457 | 291,858 | 9,403 | 13.9 K to 9.4 K (-32.16 %) |
May 06 2013 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Sell | S | 65.35 | 4,874 | 318,496 | 13,860 | 18.7 K to 13.9 K (-26.02 %) |
May 06 2013 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Buy | M | 14.39 | 4,874 | 70,137 | 18,734 | 13.9 K to 18.7 K (+35.17 %) |
May 06 2013 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Grant | A | 23.21 | 581 | 13,482 | 13,860 | 13.3 K to 13.9 K (+4.38 %) |
Mar 04 2013 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | M | 14.39 | 3,605 | 51,876 | 63,595 | |
Mar 04 2013 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | M | 17.86 | 730 | 13,038 | 67,200 | |
Mar 04 2013 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | M | 38.59 | 688 | 26,550 | 67,930 | |
Mar 04 2013 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Buy | S | 59.81 | 2,015 | 120,510 | 13,279 | 11.3 K to 13.3 K (+17.89 %) |
Mar 04 2013 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Sell | S | 59.74 | 5,023 | 300,067 | 15,294 | 20.3 K to 15.3 K (-24.72 %) |
Mar 04 2013 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Buy | M | 14.39 | 3,605 | 51,876 | 20,317 | 16.7 K to 20.3 K (+21.57 %) |
Mar 04 2013 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Buy | M | 17.86 | 730 | 13,038 | 16,712 | 16 K to 16.7 K (+4.57 %) |
Mar 04 2013 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Buy | M | 38.59 | 688 | 26,550 | 15,982 | 15.3 K to 16 K (+4.50 %) |
Nov 19 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | M | 38.59 | 10,312 | 397,940 | 68,618 | |
Nov 19 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | M | 14.39 | 5,500 | 79,145 | 78,930 | |
Nov 19 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Sell | S | 50.00 | 15,812 | 790,600 | 15,340 | 31.2 K to 15.3 K (-50.76 %) |
Nov 19 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Buy | M | 38.59 | 10,312 | 397,940 | 31,152 | 20.8 K to 31.2 K (+49.48 %) |
Nov 19 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Buy | M | 14.39 | 5,500 | 79,145 | 20,840 | 15.3 K to 20.8 K (+35.85 %) |
Nov 07 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | M | 14.39 | 8,000 | 115,120 | 84,430 | |
Nov 07 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Sell | S | 47.50 | 5,500 | 261,250 | 15,340 | 20.8 K to 15.3 K (-26.39 %) |
Nov 07 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Sell | S | 46.00 | 2,500 | 115,000 | 20,840 | 23.3 K to 20.8 K (-10.71 %) |
Nov 07 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Buy | M | 14.39 | 8,000 | 115,120 | 23,340 | 15.3 K to 23.3 K (+52.15 %) |
Jul 05 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | M | 17.86 | 2,770 | 49,472 | 94,930 | |
Jul 05 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Sell | S | 40.00 | 2,770 | 110,800 | 15,340 | 18.1 K to 15.3 K (-15.30 %) |
Jul 05 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Buy | M | 17.86 | 2,770 | 49,472 | 18,110 | 15.3 K to 18.1 K (+18.06 %) |
Jul 11 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | M | 14.39 | 2,500 | 35,975 | 92,430 | |
Jul 11 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Sell | S | 42.50 | 2,500 | 106,250 | 15,340 | 17.8 K to 15.3 K (-14.01 %) |
Jul 11 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Buy | M | 14.39 | 2,500 | 35,975 | 17,840 | 15.3 K to 17.8 K (+16.30 %) |
May 23 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | M | 0.00 | 150 | 0 | 2,462 | |
May 23 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Payment of Exercise | F | 37.98 | 56 | 2,127 | 15,340 | 15.4 K to 15.3 K (-0.36 %) |
May 23 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Buy | M | 0.00 | 150 | 0 | 15,396 | 15.2 K to 15.4 K (+0.98 %) |
May 14 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | M | 0.00 | 750 | 0 | 2,612 | |
May 14 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | M | 0.00 | 812 | 0 | 3,362 | |
May 14 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Buy | M | 0.00 | 750 | 0 | 15,246 | 14.5 K to 15.2 K (+5.17 %) |
May 14 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Buy | M | 0.00 | 812 | 0 | 14,496 | 13.7 K to 14.5 K (+5.93 %) |
May 10 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | M | 0.00 | 375 | 0 | 97,650 | |
May 10 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | M | 0.00 | 675 | 0 | 98,025 | |
May 10 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | M | 0.00 | 4,291 | 0 | 98,700 | |
May 10 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | M | 0.00 | 417 | 0 | 102,991 | |
May 10 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | M | 0.00 | 10,000 | 0 | 103,408 | |
May 10 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | A | 0.00 | 11,800 | 0 | 113,408 | |
May 10 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Sell | S | 37.50 | 15,708 | 589,050 | 13,684 | 29.4 K to 13.7 K (-53.44 %) |
May 10 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Buy | M | 17.89 | 375 | 6,709 | 29,392 | 29 K to 29.4 K (+1.29 %) |
May 10 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Buy | M | 17.89 | 625 | 11,181 | 29,017 | 28.4 K to 29 K (+2.20 %) |
May 10 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Buy | M | 17.33 | 4,291 | 74,363 | 28,392 | 24.1 K to 28.4 K (+17.80 %) |
May 10 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Buy | M | 17.54 | 417 | 7,314 | 24,101 | 23.7 K to 24.1 K (+1.76 %) |
May 10 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Buy | M | 11.74 | 10,000 | 117,400 | 23,684 | 13.7 K to 23.7 K (+73.08 %) |
May 10 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Grant | A | 0.00 | 4,720 | 0 | 13,684 | 9 K to 13.7 K (+52.66 %) |
May 10 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Grant | A | 19.35 | 664 | 12,846 | 8,964 | 8.3 K to 9 K (+8.00 %) |
Feb 28 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | M | 11.74 | 5,000 | 58,700 | 101,608 | |
Feb 28 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Sell | S | 35.07 | 5,000 | 175,325 | 8,300 | 13.3 K to 8.3 K (-37.59 %) |
Feb 28 2012 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Buy | M | 11.74 | 5,000 | 58,700 | 13,300 | 8.3 K to 13.3 K (+60.24 %) |
Jun 02 2011 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | A | 28.23 | 23,700 | 669,051 | 106,608 | |
Jun 02 2011 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Grant | A | 0.00 | 3,160 | 0 | 7,336 | 4.2 K to 7.3 K (+75.67 %) |
May 12 2011 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | M | 0.00 | 750 | 0 | 4,176 | |
May 12 2011 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | M | 0.00 | 812 | 0 | 4,926 | |
May 12 2011 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Buy | M | 0.00 | 750 | 0 | 4,175 | 3.4 K to 4.2 K (+21.90 %) |
May 12 2011 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Buy | M | 0.00 | 812 | 0 | 3,425 | 2.6 K to 3.4 K (+31.08 %) |
May 12 2011 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Grant | A | 11.64 | 1,501 | 17,466 | 2,613 | 1.1 K to 2.6 K (+134.98 %) |
Page: 1